Pharmavise Corporation, founded in 2013, provides digitally driven compliance solutions for life sciences organizations. The company's work focuses on transforming regulatory compliance into a strategic function through continuous people and process services. Its technical expertise spans several critical domains, including FDA Warning Letter Remediation, Regulatory & Quality System Compliance, Clinical & Manufacturing Audits, and Computer System Validation.
The company serves clients across the pharmaceutical, medical device, biotechnology, and broader healthcare sectors. Its operational footprint is worldwide. To date, Pharmavise has supported over 20 technical transfers, 30 product launches, and 11 FDA remediation projects.
